Press release article from our research archive:
|
|
Amgen to Webcast Investor Meeting at Upcoming American Society of Clinical Oncology Conference.(Conference news)
- Article from:
-
Business Wire
- Article date:
-
May 29, 2008
|
Copyright informationCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
THOUSAND OAKS, Calif. -- Amgen (NASDAQ:AMGN) will webcast its investor meeting at the upcoming American Society of Clinical Oncology (ASCO) Conference on Sunday, June 1 at 8 p.m. Central Time. Members of Amgen's scientific and management team will participate at the meeting. The company plans to highlight key compounds in its pipeline, including denosumab.
Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors. Information regarding presentation time, webcast availability, and webcast links are noted on Amgen's Investor Relations Events Calendar.
About Amgen
Amgen discovers, ...
Related newspaper, magazine, and journal articles:
|
AMGEN IMMUNE TO STOCK SLUMP.(Business)
Daily News (Los Angeles, CA);
October 18, 2002 ;
700+ words
......Staff Writer THOUSAND OAKS - Among all of Amgen Inc.'s creations that ward off ailments...In a sector that has fallen 9 percent, Amgen seems relatively immune to the economic...today in Thousand Oaks, is evidence of Amgen's continued strength. ``In good times and...
|
|
Amgen Announces Immunex Buy
The Washington Post;
December 17, 2001 ;
499 words
...Amgen Inc. scheduled a conference call with investors this morning...because Immunex sells a minor drug that competes with one of Amgen's drugs. The deal requires approval from shareholders. Wall Street has reacted skeptically to the idea of an Amgen buyout of Immunex, with the big company's shares ...
|
|
Amgen Announces Plans for Epratuzumab.
PR Newswire;
November 11, 2003 ;
559 words
...Amgen Inc. today announced its decision not to commence a registration...facts and circumstances regarding the product candidate, Amgen's assessment of its portfolio and other available opportunities. Epratuzumab is currently being developed by Amgen in North America and by Immunomedics, Inc. in Europe ...
|
|
Getting bigger and stronger. (Amgen Inc. manufactures and markets...
Chemistry and Industry;
June 19, 1989 ;
700+ words
...Getting bigger and stronger Amgen, the Californian biotechnology company...partner, linger as clouds on the horizon. Amgen, founded in 1980, is only the second...product. Under the name Epogen, EPO made at Amgen's headquarters in Thousand Oaks, California...
|
|
Amgen to get Synergen for $240 million
The Boston Globe;
November 19, 1994 ;
700+ words
...Plans for Amgen Corp. to build a research and development...Colo., for $240 million. Gordon M. Binder, Amgen chairman, said the company is still interested...the terms of its agreement with Synergen, Amgen will pay $9.25 for each of Synergen's nearly...
|
|
AMGEN PROFITS UP SHARPLY ANTI-ANEMIA DRUGS FUEL 47%...
Daily News (Los Angeles, CA);
July 23, 2003 ;
443 words
......Evan Pondel Staff Writer THOUSAND OAKS - Amgen Inc. saw its second-quarter profit jump...diluted share, in the year-ago period. Amgen's second-quarter revenue was $2.041 billion...earlier. ``It's a phenomenal quarter for Amgen. They beat my expectations outright...
|
|
Amgen Completes Acquisition of Abgenix; Acquisition Provides Amgen with...
Canadian Corporate News;
April 3, 2006 ;
700+ words
......Apr 3, 2006 (CCNMatthews via COMTEX) -- Amgen (NASDAQ: AMGN), the world's largest biotechnology...Abgenix stockholders overwhelmingly approved Amgen's acquisition of the company during a special...chairman and chief executive officer of Amgen. We welcome the Abgenix staff into our...
|
|
Amgen Acquires Tularik.
Daily News (Los Angeles, CA);
March 30, 2004 ;
585 words
......Pondel Mar. 30--THOUSAND OAKS, Calif. -- Amgen Inc. agreed on Monday to acquire Tularik...shares at $25 based on the average price of Amgen stock before the deal closes. The value...still subject to shareholders' approval, Amgen will be acquiring about 80 percent of the...
|
|
Amgen and Immunomedics Announce Emphasis on Development of AMG 412...
PR Newswire;
January 23, 2003 ;
700+ words
...Amgen and Immunomedics, Inc. today announced the closure of a phase...in aggressive NHL patients. Since licensing this antibody, Amgen has learned much about the action and prospects of this novel...Executive Vice President of Research and Development at Amgen. Amgen licensed Epratuzumab from ...
|
|
Court Dismisses Amgen Reimbursement Challenge.
PR Newswire;
December 24, 2002 ;
544 words
...Amgen Inc. today announced that the United States District Court for the District of Columbia dismissed Amgen's recently filed complaint against the Centers for Medicare...case was dismissed based upon the court's determination that Amgen lacked standing to challenge CMS from implementing certain...
|
|
HealthCite and AMGEN Announce Strategic Internet Alliance.
PR Newswire;
August 8, 2000 ;
468 words
...- Amgen to Invest $10 Million in Five-Year Marketing...developer and connectivity solution provider and AMGEN (Nasdaq: AMGN), the world's largest biotechnology...include a $10 million direct investment by Amgen in HealthCite with a five-year marketing...
|
|
Amgen's success recognized.
Ventura County Star (Ventura, CA);
April 10, 2005 ;
700+ words
...Byline: Allison Bruce Apr. 10--As Amgen Inc. celebrates its 25th anniversary this...biotechnology company's success and potential. Amgen, which was incorporated April 8, 1980...industry publication. Fortune, which named Amgen its company of the year for 2004, will...
|
|
Restructuring to Affect 150-250 Amgen Workers in Boulder, Colo.(Originated...
Knight Ridder/Tribune Business News;
September 5, 1997 ;
482 words
...Sep. 5--Roughly 150 to 250 Amgen employees in Boulder will be affected...and partner-search announced Thursday. Amgen said it is seeking a corporate partner...company, said Martin Simonetti, director of Amgen's Colorado operations. The rest, who...
|
|
Amgen to Make Significant Investment in Manufacturing, R&D and Commercial...
Canadian Corporate News;
January 24, 2006 ;
700+ words
......Jan 24, 2006 (CCNMatthews via COMTEX) -- Amgen (Nasdaq: AMGN), the world's largest biotechnology...operations into new markets. In Cork, Ireland, Amgen intends to invest more than $1 billion...closer to the patients it serves in Europe. Amgen currently is adding a manufacturing plant...
|
|
AMGEN RISE BIOTECH COMPANY CREATES ITS OWN BOOM.(Business)
Daily News (Los Angeles, CA);
February 5, 2002 ;
700+ words
......Evan Pondel Staff Writer THOUSAND OAKS - Amgen Inc. looks every bit the world's leading...in Baltimore. One hypothesis regarding Amgen's productivity: Kevin Sharer, chief executive...two years, Sharer has been at the helm of Amgen, tinkering with the company's management...
|
See all results.
Or, try our
Advanced Search.
|